Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition

Cervical cancer is the third most common cancer in females worldwide. The treatment options for advanced cervical cancer are limited, leading to high mortality. Ezrin is a membrane-cytoskeleton-binding protein recently reported to act as a tumor promoter, and we previously indicated that the aberran...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Jienan, Di, Chunchan, Piao, Junjie, Sun, Jie, Han, Longzhe, Chen, Liyan, Yan, Guanghai, Lin, Zhenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991407/
https://www.ncbi.nlm.nih.gov/pubmed/26933912
http://dx.doi.org/10.18632/oncotarget.7779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991407/
https://www.ncbi.nlm.nih.gov/pubmed/26933912
http://dx.doi.org/10.18632/oncotarget.7779

Ejemplares similares